​
Login / Signup
Eduardo F Farias
(Eduardo Farias)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 3
Top Topics
Genome Editing
Replacement Therapy
Crispr Cas
Basal Cell Carcinoma
Top Venues
The Journal of experimental medicine
Clinical cancer research : an official journal of the American Association for Cancer Research
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Veronica Calvo
,
Wei Zheng
,
Anna Adam-Artigues
,
Kirk A Staschke
,
Xin Huang
,
Julie F Cheung
,
Ana Rita Nobre
,
Sho Fujisawa
,
David Liu
,
Maria Fumagalli
,
David Surguladze
,
Michael E Stokes
,
Ari Nowacek
,
Mark J Mulvihill
,
Eduardo F Farias
,
Julio A Aguirre-Ghiso
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Dominic Lapadula
,
Bao Lam
,
Mizue Terai
,
Tsuyoshi Takahashi
,
Ryota Tanaka
,
Eduardo F Farias
,
Rama Kadamb
,
Melissa Lopez-Anton
,
Christian C Heine
,
Bhavik Modasia
,
Julio A Aguirre-Ghiso
,
Andrew E Aplin
,
Takami Sato
,
Jeffrey L Benovic
IGF1R inhibition enhances the therapeutic effects of Gq/11 inhibition in metastatic uveal melanoma progression.
Molecular cancer therapeutics
(2022)
Bassem D Khalil
,
Roberto Sanchez
,
Tasrina Rahman
,
Carolina Rodriguez-Tirado
,
Stefan Moritsch
,
Alba Rodriguez Martinez
,
Brett A Miles
,
Eduardo F Farias
,
Mihaly Mezei
,
Ana Rita Nobre
,
Deepak K Singh
,
Nupura Kale
,
Karl Christoph Sproll
,
Maria Soledad Sosa
,
Julio A Aguirre-Ghiso
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy.
The Journal of experimental medicine
219 (1) (2021)